Topic - Glaxosmithkline

Related Stories



A COVID-19 vaccine from drugmakers Sanofi and GlaxoSmithKline produced antibody responses on par with those who experienced natural infection, the companies said in early clinical results, paving the way for a late-stage trial in the coming weeks.

Sanofi, GlaxoSmithKline report positive trial results of COVID-19 vaccine →

The company said it is firing Moncef Slaoui from his position as board chair at Galvani Bioelectronics, effective immediately, after its investigation substantiated a complaint about his conduct toward an employee “several years ago” when Slaoui worked for the drugmaker.

Ex-US vaccine chief fired over sexual harassment allegations →

© Copyright 2022 The Washington Times, LLC
3600 New York Avenue NE, Washington, DC 20002

Switch to Desktop version